Skip to main content
Medical information Clinical review pending

Genetic Testing

Eukaryotic mRNA Sequencing and Reference Based Analysis Low Input

Eukaryotic mRNA Sequencing and Reference Based Analysis Low Input provides detailed insights into gene expression patterns, crucial for research and clinical understanding of biological processes.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Confirm with the laboratory before booking. Specific sample requirements depend on the context of the analysis.
Results
Confirm with the laboratory before booking.
Preparation
Confirm with the laboratory before booking. Preparation requirements may vary based on the sample type and research protocol.
Test priceKSh 52,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Eukaryotic mRNA Sequencing and Reference Based Analysis Low Input test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Investigating gene expression patterns.
  • ✓Studying responses to treatments or environmental factors.
  • ✓Researching genetic disorders.
  • ✓Identifying potential therapeutic targets.
  • ✓Understanding complex biological processes.
  • ✓Specific clinical investigations requiring gene expression analysis.
02

In plain language

What this test helps you understand

This test provides a detailed profile of gene expression, aiding in the understanding of biological processes, disease mechanisms, and potential therapeutic targets. It is primarily used in research settings and for specific clinical investigations.
The Eukaryotic mRNA Sequencing and Reference Based Analysis Low Input test is an advanced diagnostic tool for analysing gene expression in eukaryotic organisms. It uses cutting-edge sequencing technology to measure messenger RNA (mRNA) levels, offering a comprehensive view of which genes are active in a sample. This information is vital for researchers and clinicians studying complex biological processes at a molecular level. The analysis compares mRNA levels to reference sequences, providing detailed insights into gene activity and regulation. This test is particularly useful for investigating gene expression in different biological situations, understanding responses to treatments, and exploring the genetic basis of certain disorders.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationConfirm with the laboratory before booking. Preparation requirements may vary based on the sample type and research protocol.
SampleConfirm with the laboratory before booking. Specific sample requirements depend on the context of the analysis.
MethodologyThe test utilizes advanced sequencing technology to measure mRNA levels and compares them to reference sequences.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test provides information about gene expression at a specific point in time. Results should be interpreted in the context of the clinical picture and other relevant data. Confirm with the laboratory before booking for specific limitations.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test measures the levels of messenger RNA (mRNA) in a sample, indicating which genes are actively being expressed.
Researchers and clinicians investigating gene expression, disease mechanisms, or responses to treatments may benefit from this test.
Results provide a detailed overview of gene activity. Interpretation requires consultation with a qualified healthcare or research professional.
While it can contribute to understanding certain conditions, this test is primarily used in research and specific clinical investigations, not typically as a standalone diagnostic tool.
You can book the test by calling or WhatsApping us at +254711564616. We have branches in Nairobi, Mombasa, and Kisumu.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp